Cancer Immunotherapy Market Key Developments Enhancing Personalized Oncology Solutions
Looking toward the future, the Cancer Immunotherapy Market is poised to embrace "off-the-shelf" allogeneic therapies, which could fundamentally change the industry. Currently, many immunotherapies are autologous (derived from the patient's own cells), which is a time-consuming and expensive process. Allogeneic products, derived from healthy donors, would allow for immediate treatment...
0 Σχόλια 0 Μοιράστηκε 15 Views 0 Προεπισκόπηση